Recombinant Antibody Fragments for Neurodegenerative Diseases

BACKGROUND: Recombinant antibody fragments are promising alternatives to full-length immunoglobulins and offer important advantages compared with conventional monoclonal antibodies: extreme specificity, higher affinity, superior stability and solubility, reduced immuno-genicity as well as easy and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Manoutcharian, Karen, Perez-Garmendia, Roxanna, Gevorkian, Goar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771054/
https://www.ncbi.nlm.nih.gov/pubmed/27697033
http://dx.doi.org/10.2174/1570159X01666160930121647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771054/
https://www.ncbi.nlm.nih.gov/pubmed/27697033
http://dx.doi.org/10.2174/1570159X01666160930121647

Ejemplares similares